Regulator of gene expression responsible for the progression of breast cancer

February 28, 2014 by Bill Hathaway
Gene regulator critical for breast cancer metastasis to the lung is identified
Credit: Shutterstock

Yale Cancer Center researchers have identified a regulator of gene expression that is responsible for the progression of breast cancer and its metastasis to the lung. The study appears online in Cell Reports.

In women, breast cancer is the most common cancer, and the second leading cause of cancer-related death. When it metastasizes, it does so primarily to the lung, brain, and bone. Only limited treatment options are available, and scientists are working to identify and test new drug targets for the development of effective therapies.

Recent studies suggest that abnormal gene expression contributes significantly to tumor formation and progression. But the regulators of such changes in metastasis are poorly understood.

The Yale researchers analyzed datasets of human breast tumors, as well as those of cancer cells, and found that overexpression of the enzyme RBP2 is critical for to the lung. Loss of RBP2, they also found, suppressed in mouse models.

The authors say their evidence suggests that RBP2 regulates a critical epigenetic switch that sets the stage for . They say the enzyme offers a novel target for development of therapies designed to inhibit and metastasis.

"Metastasis is the major cause of breast cancer-related death," said senior author Qin Yan, assistant professor of pathology at Yale School of Medicine. "Our study provides the first evidence, in genetically engineered mice, that a new class of enzymes could be targeted to suppress tumor metastasis."

Explore further: New cell mechanism discovery key to stopping breast cancer metastasis

Related Stories

New cell mechanism discovery key to stopping breast cancer metastasis

January 2, 2014
Researchers from Huntsman Cancer Institute (HCI) at the University of Utah discovered a cellular mechanism that drives the spread of breast cancer to other parts of the body (metastasis), as well as a therapy which blocks ...

Study uncovers possible genetic markers in breast cancer that spreads to the brain

February 10, 2014
The Translational Genomics Research Institute (TGen) has uncovered possible genetic origins of breast cancer that spreads to the brain, according to a first-of-its-kind study published in the scientific journal PLOS ONE.

Scientists link protein with breast cancer's spread to the brain

January 6, 2014
A cancer-research team at the University of Wisconsin-Madison has identified a protein that may be a major culprit when breast cancer metastasizes to the brain.

MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients

February 5, 2013
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...

New signaling pathway linked to breast cancer metastasis

April 2, 2012
Lymph nodes help to fight off infections by producing immune cells and filtering foreign materials from the body, such as bacteria or cancer cells. Thus, one of the first places that cancer cells are found when they leave ...

Six2 homeoprotein allows breast cancer cells to detach and metastasize

April 9, 2013
In results presented at the AACR Annual Meeting 2013, researchers from the University of Colorado Cancer Center show that the Six2 homeoprotein, while not involved in primary tumor growth, allows cells to detach from substrate ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.